A detailed history of Pinnacle Bancorp, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Pinnacle Bancorp, Inc. holds 5,992 shares of ABT stock, worth $618,374. This represents 0.2% of its overall portfolio holdings.

Number of Shares
5,992
Previous 5,992 -0.0%
Holding current value
$618,374
Previous $659,000 3.34%
% of portfolio
0.2%
Previous 0.22%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024

BUY
$90.19 - $110.4 $9,920 - $12,144
110 Added 1.87%
5,992 $659,000
Q2 2023

Jul 13, 2023

SELL
$100.78 - $112.29 $16,931 - $18,864
-168 Reduced 2.78%
5,882 $641,000
Q1 2023

Apr 14, 2023

SELL
$96.86 - $114.01 $3,196 - $3,762
-33 Reduced 0.54%
6,050 $612,000
Q4 2022

Jan 24, 2023

SELL
$95.06 - $111.52 $64,165 - $75,276
-675 Reduced 9.99%
6,083 $668,000
Q1 2022

Apr 14, 2022

SELL
$114.02 - $139.04 $15,962 - $19,465
-140 Reduced 2.03%
6,758 $800,000
Q4 2021

Jan 19, 2022

SELL
$115.53 - $141.46 $5,776 - $7,073
-50 Reduced 0.72%
6,898 $971,000
Q3 2021

Oct 12, 2021

BUY
$116.66 - $129.06 $6,999 - $7,743
60 Added 0.87%
6,948 $821,000
Q1 2021

Apr 26, 2021

SELL
$108.84 - $128.23 $1,959 - $2,308
-18 Reduced 0.26%
6,888 $825,000
Q4 2020

Jan 13, 2021

SELL
$105.0 - $114.42 $13,440 - $14,645
-128 Reduced 1.82%
6,906 $756,000
Q3 2020

Oct 13, 2020

BUY
$91.64 - $111.29 $7,514 - $9,125
82 Added 1.18%
7,034 $766,000
Q1 2020

Apr 09, 2020

BUY
$62.82 - $91.86 $6,910 - $10,104
110 Added 1.61%
6,952 $549,000
Q4 2019

Jan 10, 2020

SELL
$78.51 - $87.4 $15,702 - $17,480
-200 Reduced 2.84%
6,842 $594,000
Q3 2019

Oct 08, 2019

SELL
$81.84 - $88.74 $2,618 - $2,839
-32 Reduced 0.45%
7,042 $589,000
Q1 2019

Apr 05, 2019

SELL
$66.22 - $80.06 $19,866 - $24,018
-300 Reduced 4.07%
7,074 $565,000
Q4 2018

Mar 20, 2019

BUY
$65.56 - $74.27 $483,439 - $547,666
7,374 New
7,374 $533,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $181B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Pinnacle Bancorp, Inc. Portfolio

Follow Pinnacle Bancorp, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.